Results 111 to 120 of about 534 (161)

P139: Persistent growth-promoting effects of vosoritide in children with achondroplasia for up to 4 years: Update from phase 3 extension study*

Genetics in Medicine Open
Ravi Savarirayan, Louise Tofts, Melita Irving, William Wilcox, Carlos Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Ricki Carroll, Lynda Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Carlos Prada, Daniel Hoernschemeyer, Keiichi Ozono, Takuo Kubota, Yasemin Alanay, Paul Arundel, Yumiko Kotani, Natsuo Yasui, Klane White, Shelley Brandstetter, Howard Saal, Antonio Leiva-Gea, Felipe Luna-González, Hiroshi Mochizuki, Asako Tajima, Donald Basel, Elena Fisheleva, Andrea Low, Sue Lawrinson, Jonathan Day   +33 more
doaj   +1 more source

P141: Persistent growth-promoting effects of vosoritide in children with achondroplasia is accompanied by improvement in physical aspects of quality of life*

Genetics in Medicine Open
Ravi Savarirayan, Louise Tofts, Melita Irving, William Wilcox, Carlos Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Ricki Carroll, Lynda Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Carlos Prada, Daniel Hoernschemeyer, Keiichi Ozono, Takuo Kubota, Yasemin Alanay, Paul Arundel, Yumiko Kotani, Natsuo Yasui, Klane White, Shelley Brandstetter, Howard Saal, Antonio Leiva-Gea, Felipe Luna-González, Hiroshi Mochizuki, Asako Tajima, Donald Basel, Elena Fisheleva, Richard Rowell, Alice Huntsman Labed, Jonathan Day   +33 more
doaj   +1 more source

Approach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment.

J Clin Endocrinol Metab
Merchant N, Hoover-Fong J, Carroll RS.
europepmc   +1 more source

Prediction of decline in ovarian function in Turner syndrome. [PDF]

J Endocr Soc
Kanakatti Shankar R, Dowlut-McElroy T.
europepmc   +1 more source

Foramen Magnum Stenosis in Achondroplasia: Imaging-Based Surgical Indications, Synchondrosis Fusion, and the Role of Ventriculomegaly.

Pediatr Neurosurg
Ando R, Numata O.
europepmc   +1 more source

Vosoritide Treatment Does Not Change the Robust Bone Phenotype of Children with Achondroplasia

Chloe E. Derocher, Cathleen L. Raggio, Caitlin E. Brown, Karl J. Jepsen, Erin M. Carter   +4 more
core   +1 more source

Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.

JAMA Pediatr
Savarirayan R, McDonnell C, Bacino CA, Hoernschemeyer DG, Legare JM, Abuzzahab MJ, Hofman PL, Campeau PM, de Bergua Domingo JM, Ward LM, Smit K, Smith A, Mao M, Ominsky MS, Freiberg LC, Shu AD, Hove HB.   +16 more
europepmc   +1 more source

Long-Term Growth Outcomes Following Vosoritide Therapy in a Child with Achondroplasia: A 10-Year Observational Case Study

Vivan Jena
core